ISEQ down, Elan still slipping

The ISEQ was down 26.45 points mid-morning at 6345.17, as Elan continued to slide.

ISEQ down, Elan still slipping

The ISEQ was down 26.45 points mid-morning at 6345.17, as Elan continued to slide.

After yesterday’s disastrous news of the death of a patient who was being treated with Elan’s multiple sclerosis drug Tysabri, shares in the pharmaceutical fell 96c (14.8%) this morning to €5.53.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited